(4) Some genes such as MAD2L1, RSL1D1, and CALCR were found to be significantly up-regulated in the tamoxifen-resistant cells, indicating that tamoxifen might not completely block the estrogen signaling in tamoxifen-resistant breast cancer cells. The gene discussed is RSL1D1; the disease is breast cancer.